rs144383785

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4BP6_Very_StrongBP7BS1

The NM_001160372.4(TRAPPC9):​c.3069C>T​(p.Asp1023Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000357 in 1,591,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00021 ( 0 hom. )

Consequence

TRAPPC9
NM_001160372.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0820

Publications

0 publications found
Variant links:
Genes affected
TRAPPC9 (HGNC:30832): (trafficking protein particle complex subunit 9) This gene encodes a protein that likely plays a role in NF-kappa-B signaling. Mutations in this gene have been associated with autosomal-recessive cognitive disability. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]
TRAPPC9 Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal recessive 13
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • intellectual disability-obesity-brain malformations-facial dysmorphism syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.25).
BP6
Variant 8-139732189-G-A is Benign according to our data. Variant chr8-139732189-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 212429.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.082 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00171 (261/152318) while in subpopulation AFR AF = 0.00577 (240/41576). AF 95% confidence interval is 0.00517. There are 0 homozygotes in GnomAd4. There are 124 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRAPPC9NM_001160372.4 linkc.3069C>T p.Asp1023Asp synonymous_variant Exon 22 of 23 ENST00000438773.4 NP_001153844.1 Q96Q05-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRAPPC9ENST00000438773.4 linkc.3069C>T p.Asp1023Asp synonymous_variant Exon 22 of 23 1 NM_001160372.4 ENSP00000405060.3 Q96Q05-1

Frequencies

GnomAD3 genomes
AF:
0.00171
AC:
261
AN:
152200
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00579
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000522
AC:
113
AN:
216328
AF XY:
0.000380
show subpopulations
Gnomad AFR exome
AF:
0.00688
Gnomad AMR exome
AF:
0.000275
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000473
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000305
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000213
AC:
307
AN:
1439360
Hom.:
0
Cov.:
32
AF XY:
0.000178
AC XY:
127
AN XY:
715192
show subpopulations
African (AFR)
AF:
0.00541
AC:
180
AN:
33250
American (AMR)
AF:
0.000253
AC:
11
AN:
43562
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25820
East Asian (EAS)
AF:
0.000255
AC:
10
AN:
39200
South Asian (SAS)
AF:
0.0000829
AC:
7
AN:
84440
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42130
Middle Eastern (MID)
AF:
0.000445
AC:
2
AN:
4492
European-Non Finnish (NFE)
AF:
0.0000479
AC:
53
AN:
1106774
Other (OTH)
AF:
0.000737
AC:
44
AN:
59692
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00171
AC:
261
AN:
152318
Hom.:
0
Cov.:
33
AF XY:
0.00166
AC XY:
124
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00577
AC:
240
AN:
41576
American (AMR)
AF:
0.000653
AC:
10
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68018
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000897
Hom.:
0
Bravo
AF:
0.00206
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Oct 15, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Dec 01, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.95
DANN
Benign
0.74
PhyloP100
-0.082
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144383785; hg19: chr8-140744432; API